Induction of p21WAF1/CIP1 expression has been described in colon cancer cells following treatment with COX-2 selective inhibitors [38,41,42] and recent observations from other disease models suggest this is truly a prostanoid dependent event [43]. The gene discussed is PTGS2; the disease is malignant colon neoplasm.